CMS certification 390044
Reading Hospital
420 S 5th Avenue, West Reading, PA 19611
Reading Hospital has a CMS overall rating of 4 out of 5 stars. 64% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 3. Emergency patients spend a median of 3 h 50 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 445 completed surveys, 22% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | PA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 387 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 50 min | 3 h 6 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 24 visits sampled | 5 h 6 min | 4 h 57 min | 4 h 17 min |
| Left before being seen Lower is better · 111,728 patients | 2% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 177 patients | 53% | 60% | 65% |
How Reading Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Reading HospitalThis hospital | 4/5 | 64% | 3 h 50 min | 4 better 3 worse |
| Surgical Institute of ReadingSame county · Wyomissing | Not rated | 87% | — | No different |
| Penn State Health St. JosephSame county · Reading | 3/5 | 73% | 3 h 52 min | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 7,351 cases | Too few cases | 2.7% | 3.9% |
| Heart attack 300 cases | Too few cases | 10.3% | 11.9% |
| Heart failure 1,138 cases | Too few cases | 8.5% | 11.1% |
| Pneumonia 1,103 cases | Too few cases | 12.4% | 15.2% |
| Stroke 709 cases | Too few cases | 10% | 11.9% |
| COPD 241 cases | Too few cases | 8.5% | 8.6% |
| Heart bypass surgery (CABG) 135 cases | Too few cases | 2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.17 likely 0.93 – 1.41 | 1 |
| After hip or knee replacement 373 cases | Too few cases | 3.6% | 4.1% |
| Deaths after a serious but treatable surgical complication 156 cases | No different | 152.72 per 1,000 likely 109.57 per 1,000 – 195.87 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 13,217 cases | No different | 0.79 per 1,000 likely 0.32 per 1,000 – 1.25 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 14,750 cases | No different | 0.28 per 1,000 likely 0.1 per 1,000 – 0.45 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 14,895 cases | No different | 0.16 per 1,000 likely 0 per 1,000 – 0.33 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,819 cases | No different | 2.21 per 1,000 likely 0.92 per 1,000 – 3.5 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,190 cases | No different | 1.65 per 1,000 likely 0.27 per 1,000 – 3.02 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,200 cases | No different | 9.68 per 1,000 likely 4.81 per 1,000 – 14.55 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,011 cases | No different | 3.69 per 1,000 likely 2.02 per 1,000 – 5.36 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,155 cases | No different | 8.32 per 1,000 likely 5.25 per 1,000 – 11.38 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 656 cases | No different | 2.47 per 1,000 likely 1.12 per 1,000 – 3.83 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,480 cases | No different | 1.3 per 1,000 likely 0.47 per 1,000 – 2.14 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.49 likely 0.24 – 0.91 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.61 likely 0.31 – 1.09 | 1 |
| Surgical site infections after colon surgery | No different | 1.42 likely 0.75 – 2.47 | 1 |
| Surgical site infections after abdominal hysterectomy | Worse | 3.02 likely 1.22 – 6.27 | 1 |
| MRSA bloodstream infections | No different | 0.72 likely 0.31 – 1.41 | 1 |
| C. diff intestinal infections | Better | 0.36 likely 0.25 – 0.5 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 455 cases | Too few cases | 16.1% | 14.4% |
| Readmitted after heart failure 1,775 cases | Too few cases | 24.1% | 21.3% |
| Readmitted after pneumonia 1,721 cases | Too few cases | 17.3% | 17.3% |
| Readmitted after COPD 502 cases | Too few cases | 22.7% | 20% |
| Readmitted after heart bypass surgery 160 cases | Too few cases | 14% | 11% |
| Readmitted after hip or knee replacement 380 cases | Too few cases | 5.3% | 5.8% |
| Days back in hospital after a heart attack 305 cases | Too few cases | 29.4 days per 100 | — |
| Days back in hospital after heart failure 1,331 cases | Too few cases | 5.2 days per 100 | — |
| Days back in hospital after pneumonia 1,136 cases | Too few cases | 5.5 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 652 cases | No different | 11.8 per 1,000 likely 9 per 1,000 – 15.4 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 393 cases | Worse | 14.4 per 100 likely 11.9 per 100 – 17.3 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 393 cases | No different | 4.9 per 100 likely 3.6 per 100 – 6.7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 804 cases | No different | 1 likely 0.8 – 1.2 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
422 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 208 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 90 |
| Emergency Medicine | 44 |
| Anesthesiology | 27 |
| Surgery | 22 |
| Family Medicine | 20 |
| Nurse Practitioner | 19 |
| Physician Assistant | 16 |
| Obstetrics & Gynecology | 12 |
| Pharmacist | 12 |
| Nurse Anesthetist, Certified Registered | 11 |
| Psychiatry | 10 |
| Family | 8 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $317,627
- 2020 $646,712
- 2021 $468,472
- 2022 $289,321
- 2023 $272,074
- 2024 $825,300
- 2025 $691,377
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $91,560 | 2 |
| Speaking, teaching and other services | $30,550 | 34 |
| Debt forgiveness | $14,525 | 8 |
| Space rental and facility fees | $12,750 | 6 |
| Education | $10,098 | 1 |
| Medical devices and supplies on long-term loan | $830 | 1 |
| Gifts | $750 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Genentech, Inc. | $174,797 | 56 |
| Janssen Research & Development, LLC | $161,312 | 30 |
| Pfizer INC. | $67,310 | 2 |
| BeiGene, Ltd. | $33,536 | 1 |
| BeOne Medicines USA, Inc. | $30,590 | 4 |
| EMD Serono, Inc. | $26,920 | 2 |
| Daiichi Sankyo Inc. | $26,651 | 2 |
| Insulet Corporation | $26,125 | 24 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivanta… Janssen Research & Development, LLC | $94,600 |
| A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies (MorningSu… Genentech, Inc. | $68,969 |
| Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC Genentech, Inc. | $66,630 |
| A Phase 3 Randomized Double-Blind Multicenter Study of Sonrotoclax Plus Zanubrutinib Versus Placebo Plus Zanubrutinib in Patients With Relapsed/Refra… BeiGene, Ltd. · NCT06742996 | $64,126 |
| A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination with Lazertinib as First-Line Treatment, or Subcutaneous Amivanta… Janssen Research & Development, LLC | $30,021 |
| A Multicenter, Observational Study to Characterize the Clinical Course in a Real-World, US Cohort of Patients with Relapsing Multiple Sclerosis of Ad… EMD Serono, Inc. | $26,920 |
| DS8201-A-U305 Daiichi Sankyo Inc. · NCT04622319 | $26,651 |
| A Phase IV, Longitudinal, Observational Study Examining Real-World Outcomes of Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersom… Astellas Pharma Global Development | $23,646 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Reading Hospital
Is Reading Hospital a good hospital?
Reading Hospital has a CMS overall rating of 4 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Reading Hospital?
64% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 445 completed HCAHPS surveys.
How long is the wait in the Reading Hospital emergency room?
Emergency patients spend a median of 3 h 50 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Reading Hospital receive money from drug and device companies?
Drug and device makers reported $691,377 in payments to Reading Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.